About POINT Biopharma
POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer
Revenue:$10M - $20M
|
|
|
51-200 employees
View all POINT Biopharma employees
|
|
Biotechnology
|
|
22 St Clair Avenue East, Suite 1201, Toronto, Ontario M4T2S3, CA
|
|
2019
|
|
Cancer, Oncology, Radiopharmaceutical, Radioligand
|
POINT Biopharma Alternatives
POINT Biopharma Staff Directory
Search POINT Biopharma Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
